Termination by Institution or Investigator. Institution or Investigator may terminate this Agreement upon thirty (30) days written notice to Idorsia if Institution or Investigator has reasonable medical basis based on data to believe that the continuation of the Protocol is detrimental to the health or safety of Subject(s) participating in the Study.
Appears in 3 contracts
Samples: Clinical Trial Agreement, Clinical Trial Agreement, Clinical Trial Agreement
Termination by Institution or Investigator. Institution or Investigator may terminate this Agreement upon thirty (30) days written notice no- xxxx to Idorsia if Institution or Investigator has reasonable medical basis based on data to believe that the continuation of the Protocol is detrimental to the health or safety of Subject(sSub- ject(s) participating in the Study.
Appears in 2 contracts
Termination by Institution or Investigator. Institution or Investigator may terminate this Agreement upon thirty (30) days written notice to Idorsia Actelion if Institution or Investigator has reasonable medical basis based on data to believe that the continuation of the Protocol is detrimental to the health or safety of Subject(s) participating in the Study.
Appears in 2 contracts
